Presentation to share PIVOT, a KU patient-researcher advocacy initiative
The latest news and information for the University of Kansas.
Stay updated with breaking news from Molecular Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The latest news and information for the University of Kansas.
<p>Stanford researchers who previously pioneered a new kind of protein degradation have mapped out how the process works, which could lead to new drug therapies for diseases like Alzheimer’s and cancer, and for rare childhood enzyme disorders.</p>
Benjamin Miron, MD, explains the purpose of studying the molecular profile of intraductal carcinoma of the prostate, expands on the potential prognostic and targetable alterations identified in patients with this histology, and discusses the planned cohort expansion and analysis of RNA signatures in this population.
LOS ANGELES, June 1 (Xinhua) -- The U.S. National Cancer Institute (NCI) has launched a large precision medicine cancer initiative to test the effectiveness of treating adults and children with new drug combinations that target specific tumor alterations, the institute said on Thursday.
U.S. launches new initiative testing tumor drug combinations-